why choose us

First received: August 4, 2022

Clinical Trial: "Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

Study Status: Completed

Recruit Status: Completed

Condition: Rectal Cancer, Adenocarcinoma
Rectal Cancer Stage II
Rectal Cancer Stage III
Distant

Study Type: Observational [Patient Registry]


Official Title: Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and pCR After Neoadjuvant Treatment.

Brief Summary: Pathologic complete response (pCR) after multimodal treatment for locally advanced rectal cancer (LARC) patients is considered as the gold-standard of treatment success as it is associated to privileged oncologic outcome. Nevertheless, data from multicenter high-volume cohorts with long term follow-up are scarce.This is a multicenter observational study using prospectively collected data from the Spanish Rectal Cancer Project database.The main objective of the study is to update long-term oncologic follow-up of…

Read more